Denver Regional Transportation District (RTD) board of directors approved a request from the University of Colorado (CU) Anschutz Medical Campus to relocate the planned Montview Station on the I-225 Rail Line to a new location at Fitzsimons Parkway.

CU officials requested the station be moved due to concerns for adequate mitigation of electromagnetic interference (EMI) and vibration near sensitive research equipment at current and future medical buildings.

The decision by the board of directors will allow the I-225 project team to identify environmental impacts and propose mitigation before moving forward with design and construction.

“We will continue to collaborate with our partners to ensure that our project meets the needs of the greater community,” said RTD GM Phil Washington. “We will develop a solution that keeps the project moving forward while staying on budget.”

During the 2007 to 2009 environmental and early design process, RTD and CU evaluated options for mitigating EMI and vibration from the train, but found that previous measures identified might not be sufficient for future technologies. Additional methods of mitigation were considered but found to be too costly. The project team aims to have a new alignment and station site determined with design underway by the end of the year.

The I-225 Rail Line is a 10.5-mile light rail extension that will travel through the City of Aurora and make key connections to the Anschutz Medical Campus and the future VA Hospital.

The line, part of RTD’s FasTracks program, will link the existing Southeast Light Rail Line at the Nine Mile Station with the planned East Rail Line at the Peoria Station and will include eight stations.

RELATED: "Denver RTD Generating Innovative Ideas to Fuel Expansion."

About the author
Staff Writer

Staff Writer

Editorial

Our team of enterprising editors brings years of experience covering the fleet industry. We offer a deep understanding of trends and the ever-evolving landscapes we cover in fleet, trucking, and transportation.  

View Bio
0 Comments